Please enable JavaScript.
Coggle requires JavaScript to display documents.
Should the United States federal government implement value-based pricing…
Should the United States federal government implement value-based pricing for pharmaceuticals?
Political
Lobbying from Pharma
Libertarians and their stance on not having prices
Congressional Bills in action
Other nations like Sweden
Drug lag caused by negotiations
Medicare
Economic
Shray
Marketing spending
Funding
Stock
Institutional investors
Mergers and Acquisitions
Drug Shortages
Scientific
Innovation Funding
NMEs vs NCEs
Government funded R&D
Global Innovation goes down
Lextro/Dextroisomers
Brand name drugs
Generic Drugs
Orphan diseases with small samples
Legal
Black market
Illegal Drug Crisis
Drug abuse and law enforcement effects
Inlicensing - giant companies